LFST
LifeStance Health Group, Inc.
+0.15 (+1.13%)12.94USD4.4M成交股數4.9B市值–本益比(近四季)3.1股價營收比+26.1%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 435M+26% | 403M+21% | 382M+22% | 364M+16% | 345M+15% | 333M+19% | 313M+19% | 312M+20% | 300M | 281M | 263M | 260M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 108M | 100M | 94.8M | 95.6M | 97.4M | 94.4M | 85.3M | 95.2M | 88.9M | 93.4M | 131M | 102M |
| 營業利益 | 30.7M-1139% | 22.3M+1289% | 18.1M+38377% | 7.4M-146% | −3.0M-82% | 1.6M-105% | 47K-100% | −15.9M-67% | −16.8M | −32.3M | −74.4M | −48.4M |
| 營業利益率 | 7.0% | 5.5% | 4.7% | 2.0% | -0.9% | 0.5% | 0.0% | -5.1% | -5.6% | -11.5% | -28.3% | -18.7% |
| 稅後淨利 | 23.6M-723% | 14.2M+1909% | 11.7M+1546% | 1.1M-105% | −3.8M-82% | 709K-102% | 709K-101% | −23.3M-49% | −21.1M | −45.0M | −61.6M | −45.5M |
| 淨利率 | 5.4% | 3.5% | 3.1% | 0.3% | -1.1% | 0.2% | 0.2% | -7.5% | -7.0% | -16.0% | -23.4% | -17.5% |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | 387M | 395M | 391M | 389M | 387M | 391M | 380M | 379M | 376M | 367M | 372M | 363M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 226M | 195M | 249M | 204M | 189M | 134M | 103M | 87.0M | 49.5M | 78.8M | 42.6M | 79.6M |
| 應收帳款 | 111M | 123M | 95.7M | 121M | 129M | 140M | 158M | 167M | 176M | 125M | 150M | 122M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 2.2B | 2.1B | 2.2B | 2.1B | 2.1B | 2.1B | 2.1B | 2.1B | 2.1B | 2.1B | 2.2B | 2.2B |
| 有息負債 | 259M | 262M | 266M | 269M | 273M | 276M | 279M | 279M | 280M | 280M | 248M | 249M |
| 總負債 | 704M | 668M | 683M | 656M | 673M | 648M | 671M | 689M | 677M | 681M | 720M | 676M |
| 股東權益 | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.5B | 1.4B | 1.4B | 1.4B | 1.4B | 1.5B | 1.5B |
| 負債比 | 32.3% | 31.2% | 31.0% | 30.5% | 31.3% | 30.8% | 31.8% | 32.5% | 32.2% | 32.3% | 33.1% | 31.1% |
| 淨現金(現金 − 有息負債) | −33.0M | −67.7M | −17.3M | −65.5M | −83.9M | −142M | −176M | −192M | −230M | −201M | −206M | −169M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 33.1M-1171% | – | – | – | −3.1M | – | – | −21.8M | – | – | – |
| 資本支出 | – | 10.8M | – | – | – | 7.2M | – | – | 5.1M | – | – | – |
| 自由現金流 | – | 22.3M-318% | – | – | – | −10.3M | – | – | −26.9M | – | – | – |
| 折舊攤銷 | 11.3M | 10.4M | 10.3M | 10.3M | 10.6M | 10.3M | 10.4M | 10.1M | 10.0M | 9.7M | 9.4M | 9.4M |
| 買回庫藏股 | – | 49.1M | – | – | – | 0.00 | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 5.5% | – | – | – | -3.1% | – | – | -9.0% | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.4B | +13.9% | 9.7M | 0.7% | – | 110M |
| FY2024 | 1.3B | +18.5% | −57.4M | -4.6% | – | 85.7M |
| FY2023 | 1.1B | +22.8% | −186M | -17.6% | – | −57.4M |
| FY2022 | 860M | +59383.9% | −216M | -25.1% | – | −26.5M |
| FY2021 | 1.4M | -99.3% | −307M | -21,259.3% | – | −85.1M |
| FY2019 | 213M | – | 5.7M | 2.7% | – | 2.7M |